4.7 Editorial Material

Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline

Journal

NANOMEDICINE
Volume 15, Issue 26, Pages 2539-2542

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2020-0290

Keywords

fenretinide; L-asparaginase; nanotechnology; seriniquinone

Funding

  1. Sao Paulo Research Foundation (FAPESP) [2018/13877-1, 2015/17177-6, 2013/08617-7]
  2. CNPQ [165935/2019-7]
  3. CAPES [001]
  4. FAPESP [2018/14375-0, 2018/07661-6]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available